Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Recombinant MUC1 mucin wi… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.

Artikel i vetenskaplig tidskrift
Författare Malin Bäckström
Thomas Link
Fredrik J. Olson
Hasse Karlsson
Rosalind Graham
Gianfranco Picco
Joy Burchell
Joyce Taylor-Papadimitriou
Thomas Noll
Gunnar C. Hansson
Publicerad i The Biochemical journal
Volym 376
Nummer/häfte Pt 3
Sidor 677-86
ISSN 1470-8728
Publiceringsår 2003
Publicerad vid Institutionen för medicinsk och fysiologisk kemi
Sidor 677-86
Språk en
Länkar dx.doi.org/10.1042/BJ20031130
Ämnesord Amino Acids, analysis, Animals, Antibodies, Monoclonal, immunology, Breast Neoplasms, metabolism, CHO Cells, Carbohydrate Sequence, Carcinoma, metabolism, Cell Line, Tumor, Cricetinae, Female, Glycosylation, Humans, Immunoglobulin G, genetics, Molecular Sequence Data, Mucin-1, chemistry, genetics, metabolism, Polysaccharides, chemistry, Recombinant Fusion Proteins, chemistry, isolation & purification, metabolism
Ämneskategorier Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci)

Sammanfattning

We have developed an expression system for the production of large quantities of recombinant MUC1 mucin in CHO-K1 (Chinese-hamster ovary K1) cells. The extracellular part of human MUC1, including 16 MUC1 tandem repeats, was produced as a fusion protein with murine IgG Fc, with an intervening enterokinase cleavage site for the removal of the Fc tail. Stable MUC1-IgG-producing CHO-K1 clones were generated and were found to secrete MUC1-IgG into the culture medium. After adaptation to suspension culture in protein-free medium in a bioreactor, the fusion protein was secreted in large quantities (100 mg/l per day) into the culture supernatant. From there, MUC1 could be purified to homogeneity using a two-step procedure including enterokinase cleavage and ion-exchange chromatography. Capillary liquid chromatography MS of released oligosaccharides from CHO-K1-produced MUC1 identified the main O-glycans as Galbeta1-3GalNAc (core 1) and mono- and di-sialylated core 1. The glycans occupied on average 4.3 of the five potential O-glycosylation sites in the tandem repeats, as determined by nano-liquid chromatography MS of partially deglycosylated Clostripain-digested protein. A very similar O-glycan profile and site occupancy was found in MUC1-IgG produced in the breast carcinoma cell line T47D, which has O-glycosylation typical for breast cancer. In contrast, MUC1-IgG produced in another breast cancer cell line, MCF-7, showed a more complex pattern with both core 1- and core 2-based O-glycans. This is the first reported production of large quantities of recombinant MUC1 with a breast cancer-like O-glycosylation that could be used for the immunotherapy of breast cancer.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?